CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	6 Months Ended		88 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014
Operating activities
Net loss	$ (1,043,253)	$ (1,161,625)	$ (9,066,513)
Adjustments to reconcile net income to net cash provided (used) by operating activities
Depreciation	16,992	16,992	219,174
Change in allowance for uncollectible note receivable			38,867
Amortization of deferred financing costs		51,437	59,605
Interest (income) expense on fair value adjustment	259,541	(4,464)	724,406
Loss on extinguishment of debt			381,113
Write-off of uncollectible deposits			20,000
Accrued interest on note receivable			(11,705)
Loss on impairment			42,800
Amortization of beneficial conversion feature of the notes payable	187,477		365,906
Common stock issued for services	141,759	937,037	3,123,154
Common stock issued for legal services	7,683		130,106
Common stock issued for financing fees			5,000
Decrease (increase) in:
Prepaid expenses	4,527	(185,862)	(34,543)
Advances from shareholder	(7,542)		(8,557)
Deposits and other receivables			(23,346)
Accounts payable and accrued expenses	(3,139)	4,223	231,375
Net cash provided (used) by operating activities	(435,954)	(342,262)	(3,803,158)
Cash flows from investing activities:
Principal payments from notes receivable			(25,000)
Purchase of common stock			(34,100)
Property and equipment acquisitions			(325,000)
Net cash provided (used) by investing activities			(384,100)
Cash flows from financing activities:
Proceeds from the issuance of common stock	233,266	193,843	2,559,153
Proceeds from the issuance of convertible notes payable	235,005	55,500	1,142,305
Proceeds from the issuance of convertible notes payable, related party	43,505	79,000	207,000
Proceeds from issuance of notes payable			476,500
Proceeds from issuance of notes payable, related parties			8,500
Payments on convertible notes payable		(30,000)	(76,000)
Payments on notes payable			(57,500)
Payments on notes payable, related parties			(1,000)
Proceeds from loans from stockholders			49,675
Payments on loans from stockholders			(44,975)
Net cash provided by financing activities	511,776	298,343	4,263,658
Net increase (decrease) in cash	75,822	(43,919)	76,400
Cash - beginning	578	43,919
Cash - ending	76,400		76,400
Supplemental disclosure of cash flow information:
Cash paid for interest expense			3,660
Cash paid for income taxes
Noncash operating and financing activities:
Due to Organetix, Inc. reclassified to additional paid-in capital			91,500
Common stock issued in connection with a joint venture			9,800
Common stock issued to satisfy debt	7,683		140,870
Common stock issued to satisfy minimum value guaranteed			87,667
Convertible debt converted and accrued interest to common stock	61,400		1,571,000
Common stock issued in exchange for property and equipment			$ 7,420